BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Blocking unfolded protein response, integrated stress response for necrotizing fasciitis, lung cancer

By Claire Quang, Staff Writer
August 27, 2021 9:20 PM UTC

DISEASE CATEGORY: Infectious disease; cancer

INDICATION: Streptococcus; lung cancer...

BCIQ Company Profiles

Hebrew University of Jerusalem

Mcgill University

University of Leicester

BCIQ Target Profiles

Eukaryotic translation initiation factor 2 (eIF2) alpha kinase 3 (PERK) (EIF2AK3)

Eukaryotic translation initiation factor 2 (eIF2) subunit alpha (eIF-2alpha) (EIF2S1)

BCIQ Company Profiles

Hebrew University of Jerusalem

Mcgill University

University of Leicester

BCIQ Target Profiles

Eukaryotic translation initiation factor 2 (eIF2) alpha kinase 3 (PERK) (EIF2AK3)

Eukaryotic translation initiation factor 2 (eIF2) subunit alpha (eIF-2alpha) (EIF2S1)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS